Filing Details

Accession Number:
0001140361-10-026302
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-21 13:00:00
Reporting Period:
2010-06-18
Filing Date:
2010-06-21
Accepted Time:
2010-06-21 16:57:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1092601 Spa Finanziaria Tau Sigma Via Sudafrica, 20
Rome L6 00144
No No Yes No
1170881 Sa International Tau Sigma 19-21 Boulevard Du Prince Henri
L-1724 N4 00000
No No Yes No
1385625 Sigma-Tau Pharmaceuticals, Inc. 9841 Washingtonian Blvd.
Suite 500
Gaithersburg MD 20878
No No Yes No
1385930 S.a. America Sigma-Tau 19-21 Boulvard Du Prince Henri
L-1724 N4 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-18 8,608,580 $0.21 54,227,816 No 4 P Indirect Indirect
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Indirect
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2010-06-18 1 $0.00 5,165,148 $0.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2010-06-18 2015-06-18 No 4 J Indirect
Footnotes
  1. Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. ("Pharmaceuticals"). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. ("America"). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. ("International"). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A.
  2. This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals' purchase of 8,608,580 shares of common stock on June 18, 2010.
  3. The expiration date of the warrant may be accelerated at the Issuer's option if the Issuers's common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended.